Authors: Kempf, DJ Isaacson, JD King, MS Brun, SC Xu, Y Real, K Bernstein, BM Japour, AJ Sun, E Rode, RA

Citation: Dj. Kempf et al., Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients, J VIROLOGY, 75(16), 2001, pp. 7462-7469

Authors: Gisolf, EH Jurriaans, S Pelgrom, J van Wanzeele, F van der Ende, ME Brinkman, K Borst, MJ de Wolf, F Japour, AJ Danner, SA

Citation: Eh. Gisolf et al., The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine, AIDS, 14(4), 2000, pp. 405-413

Authors: Welles, SL Pitt, J Colgrove, R McIntosh, K Chung, PH Colson, A Lockman, S Fowler, MG Hanson, C Landesman, S Moye, J Rich, KC Zorrilla, C Japour, AJ

Citation: Sl. Welles et al., HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infanttransmission in the Women and Infants Transmission Study, AIDS, 14(3), 2000, pp. 263-271

Authors: Cameron, DW Japour, AJ Xu, Y Hsu, A Mellors, J Farthing, C Cohen, C Poretz, D Markowitz, M Follansbee, S Angel, JB McMahon, D Ho, D Devanarayan, V Rode, R Salgo, MP Kempf, DJ Granneman, R Leonard, JM Sun, E

Citation: Dw. Cameron et al., Ritonavir and saquinavir combination therapy for the treatment of HIV infection, AIDS, 13(2), 1999, pp. 213-224

Authors: Sham, HL Kempf, DJ Molla, A Marsh, KC Kumar, GN Chen, CM Kati, W Stewart, K Lal, R Hsu, A Betebenner, D Korneyeva, M Vasavanonda, S McDonald, E Saldivar, A Wideburg, N Chen, XQ Niu, P Park, C Jayanti, V Grabowski, B Granneman, GR Sun, E Japour, AJ Leonard, JM Plattner, JJ Norbeck, DW

Citation: Hl. Sham et al., ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease, ANTIM AG CH, 42(12), 1998, pp. 3218-3224